Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation

CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …

Immunogenicity of a combined diphtheria–tetanus–acellular pertussis vaccine in adults

P Van Damme, M Burgess - Vaccine, 2004 - Elsevier
Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …

Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane …

G Kanra, M Ceyhan, D Vandevoorde… - European journal of …, 1993 - Springer
In two double-blind, randomized, comparative studies involving a total of 218 children, an
acellular pertussis (DTPa) vaccine containing diphtheria and tetanus toxoids and pertussis …

Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants

EL Anderson, RB Belshe… - Journal of Infectious …, 1988 - academic.oup.com
Clinical and serological responses of infants to primary immunization with diphtheria-tetanus-
pertussis (DTP) vaccine containing components of acellular pertussis vaccine (DTP-AC) …

Immunogenicity and reactogenicity of a reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents

LM Huang, LY Chang, H Tang, HL Bock, CY Lu… - Journal of Adolescent …, 2005 - Elsevier
PURPOSE: Disease caused by Bordetella pertussis is increasingly being identified among
older children and adults in immunized populations, indicating a waning of the vaccine …

Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine

F Zepp, M Knuf, P Habermehl… - The Journal of …, 2006 - Elsevier
OBJECTIVE: The safety of a booster dose of a reduced-antigen-content tetanus–diphtheria–
acellular pertussis (Tdap) vaccine was evaluated in adolescents previously vaccinated with …

[PDF][PDF] Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean …

LPC Shek, ESH Khor, GH Tan, KT Low… - … Asian journal of …, 2003 - researchgate.net
The objective of this study was to assess and compare the reactogenicity of GlaxoSmithKline
(GSK) Biologicals' diphtheria-tetanus-tricomponent acellular pertussis vaccine (DTPa) and …

Reduced-antigen-content-diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine as a booster for adolescents 10 to 14 years of age

R Vergara, M Tregnaghi, J Ussher, S Navarro… - European journal of …, 2005 - Springer
High rates of pertussis disease in adolescents suggest that additional boosting against
pertussis would be beneficial. A combined acellular-pertussis-containing booster vaccine …

Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan

M Hara, K Okada, Y Yamaguchi, S Uno… - Clinical and Vaccine …, 2013 - Am Soc Microbiol
The recent increase of pertussis in young adults in Japan is hypothesized to be due in part
to waning protection from the acellular pertussis vaccine. While a booster immunization may …

Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15–24 months and 4–6 years of age

BS Auerbach, ME Wilson, AM Lake, A Deforest… - Vaccine, 1992 - Elsevier
In a randomized double-blind trial 55 children of 15–24 months and 56 children of 4–6 years
of age previously immunized with whole-cell DTP (WC-DTP) received acellular pertussis …